Urinary dopamine sulfate conjugates in Parkinson’s disease-Reference-Cited by-同舟云学术

Urinary dopamine sulfate conjugates in Parkinson’s disease

Published:1990 Issue: Volume: Page:79-92
ISSN:0938-9245
Container-title:New Vistas in Drug Research
language:
Short-container-title:

Author:

Kienzl E.,Eichinger K.,Jellinger K.,Kuhn W.,Fuchs G.,Danielczyk W.,Wesemann W.,Riederer P.

Publisher

Springer Vienna

Link

http://link.springer.com/content/pdf/10.1007/978-3-7091-9098-2_10.pdf

Reference42 articles.

1. Arakawa Y, Imai K, Tamura Z (1979) High-performance liquid chromatographic determination of dopamine sulfoconjugates in urine after L-dopa administration. J Chromatogr 162: 311–318

2. Bacopoulos NG, Hattox SE, Roth RH (1979) 3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: possible indicators of central dopaminergic activity. Eur J Pharmacol 56: 225–236

3. Barbeau A (1961) Biochemistry of Parkinson’s disease. Excerpta Medica, ICS 38: 152–153

4. Barbeau A (1969) Parkinson’s disease as a systemic disorder. In: Gillingham FJ, Sonaldson ML (eds) 3rd Symposium on Parkinson’s disease. Edinburgh, Livingstone, pp 66–73

5. Barbeau A (1975) Pathophysiology of the oscillations in performance after long-term therapy with L-dopa. In: Birkmayer W, Hornykiewicz O (eds) Advances in parkinsonism. Editions Roche, Basel, pp 424–434

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human brain phenolsulfotransferase. Regional distribution in Parkinson's disease;Journal of Neural Transmission - Parkinson's Disease and Dementia Section;1992-12

2. Urinary dopamine sulfate: regulations and significance in neurological disorders;Amine Oxidases and Their Impact on Neurobiology;1990